BlackRock’s Sensus Healthcare SRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $283K | Buy |
71,167
+412
| +0.6% | +$1.83K | ﹤0.01% | 4670 |
|
|
2025
Q4 | $282K | Sell |
70,755
-2,522
| -3% | -$9.35K | ﹤0.01% | 4630 |
|
|
2025
Q3 | $230K | Buy |
73,277
+1,879
| +3% | +$7.38K | ﹤0.01% | 4654 |
|
|
2025
Q2 | $338K | Buy |
71,398
+5,552
| +8% | +$26K | ﹤0.01% | 4534 |
|
|
2025
Q1 | $311K | Sell |
65,846
-14,700
| -18% | -$85.6K | ﹤0.01% | 4520 |
|
|
2024
Q4 | $557K | Buy |
80,546
+14,191
| +21% | +$104K | ﹤0.01% | 4381 |
|
|
2024
Q3 | $385K | Buy |
66,355
+1,449
| +2% | +$8.8K | ﹤0.01% | 4390 |
|
|
2024
Q2 | $346K | Buy |
64,906
+1,123
| +2% | +$5.16K | ﹤0.01% | 4430 |
|
|
2024
Q1 | $242K | Sell |
63,783
-2,314
| -4% | -$8.39K | ﹤0.01% | 4544 |
|
|
2023
Q4 | $156K | Buy |
66,097
+1,917
| +3% | +$4.49K | ﹤0.01% | 4700 |
|
|
2023
Q3 | $178K | Sell |
64,180
-5,026
| -7% | -$15.4K | ﹤0.01% | 4713 |
|
|
2023
Q2 | $218K | Buy |
69,206
+8,180
| +13% | +$29.5K | ﹤0.01% | 4712 |
|
|
2023
Q1 | $318K | Sell |
61,026
-448
| -0.7% | -$3.22K | ﹤0.01% | 4656 |
|
|
2022
Q4 | $456K | Buy |
61,474
+1,377
| +2% | +$12.4K | ﹤0.01% | 4632 |
|
|
2022
Q3 | $753K | Buy |
60,097
+8,774
| +17% | +$105K | ﹤0.01% | 4584 |
|
|
2022
Q2 | $394K | Sell |
51,323
-71,950
| -58% | -$604K | ﹤0.01% | 4850 |
|
|
2022
Q1 | $1.25M | Sell |
123,273
-151
| -0.1% | -$1.38K | ﹤0.01% | 4591 |
|
|
2021
Q4 | $890K | Buy |
123,424
+910
| +0.7% | +$4.98K | ﹤0.01% | 4702 |
|
|
2021
Q3 | $441K | Buy |
122,514
+1,804
| +1% | +$6.6K | ﹤0.01% | 4791 |
|
|
2021
Q2 | $465K | Buy |
120,710
+2,273
| +2% | +$8.53K | ﹤0.01% | 4709 |
|
|
2021
Q1 | $453K | Buy |
118,437
+4,748
| +4% | +$19.5K | ﹤0.01% | 4621 |
|
|
2020
Q4 | $439K | Buy |
113,689
+2,661
| +2% | +$8.12K | ﹤0.01% | 4371 |
|
|
2020
Q3 | $279K | Sell |
111,028
-3,097
| -3% | -$8.73K | ﹤0.01% | 4348 |
|
|
2020
Q2 | $349K | Buy |
114,125
+5,106
| +5% | +$13.3K | ﹤0.01% | 4275 |
|
|
2020
Q1 | $273K | Buy |
109,019
+3,120
| +3% | +$11.6K | ﹤0.01% | 4172 |
|
|
2019
Q4 | $375K | Buy |
105,899
+712
| +0.7% | +$3.22K | ﹤0.01% | 4208 |
|
|
2019
Q3 | $631K | Buy |
105,187
+1,544
| +1% | +$8.98K | ﹤0.01% | 4111 |
|
|
2019
Q2 | $574K | Buy |
103,643
+29,990
| +41% | +$176K | ﹤0.01% | 4160 |
|
|
2019
Q1 | $517K | Buy |
73,653
+47,622
| +183% | +$368K | ﹤0.01% | 4095 |
|
|
2018
Q4 | $192K | Buy |
26,031
+2,418
| +10% | +$15.4K | ﹤0.01% | 4241 |
|
|
2018
Q3 | $198K | Buy |
23,613
+963
| +4% | +$6.97K | ﹤0.01% | 4317 |
|
|
2018
Q2 | $164K | Buy |
+22,650
| New | +$148K | ﹤0.01% | 4361 |
|
|
2017
Q2 | – | Sell |
-309
| Closed | -$1K | – | 5100 |
|
|
2017
Q1 | $1K | Buy |
+309
| New | +$1.46K | ﹤0.01% | 4956 |
|
Other funds holding SRTS
PRCP
VCM
DSCM
MIM
S
GWM
BlackRock's SRTS Position: Q1 2026 in Review
BlackRock increased its Sensus Healthcare (SRTS) stake by 0.58% in Q1 2026, buying an estimated $1.83K and bringing the position to 71,167 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #4670.
BlackRock first reported a position in SRTS in Q1 2017 and has held it in 33 quarters since. The position peaked at $1.25M in Q1 2022. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.
- BlackRock held 71,167 shares of Sensus Healthcare worth $283K as of Q1 2026.
- BlackRock bought 412 Sensus Healthcare shares in Q1 2026, an estimated $1.83K.
- Sensus Healthcare made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4670 holding.
- BlackRock first reported a position in Sensus Healthcare in Q1 2017 and has held it in 33 quarters since.
- BlackRock's Sensus Healthcare position peaked at $1.25M in Q1 2022.
- 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.